**Headline:** Can-Fite Granted Canadian Patent for Namodenoson in Obesity Treatment
Can-Fite Pharmaceuticals has received a patent allowance in Canada for the use of Namodenoson as a therapy for obesity. The drug’s oral safety profile and its effects on metabolism support its potential application in managing obesity. Namodenoson is being developed to address the increasing demand for effective obesity treatments. The …